首页 > 最新文献

JU Open Plus最新文献

英文 中文
June 2024 JUOP: Celebrating Dr Patrick Walsh’s 50th Year at the Brady Urological Institute 2024 年 6 月 JUOP:庆祝帕特里克-沃尔什(Patrick Walsh)博士在布雷迪泌尿研究所工作 50 周年
Pub Date : 2024-07-01 DOI: 10.1097/ju9.0000000000000189
Marissa Clifton, John W. Davis
{"title":"June 2024 JUOP: Celebrating Dr Patrick Walsh’s 50th Year at the Brady Urological Institute","authors":"Marissa Clifton, John W. Davis","doi":"10.1097/ju9.0000000000000189","DOIUrl":"https://doi.org/10.1097/ju9.0000000000000189","url":null,"abstract":"","PeriodicalId":508272,"journal":{"name":"JU Open Plus","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141852897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-World Evidence That a Novel Diagnostic Combining Molecular Testing With Pooled Antibiotic Susceptibility Testing is Associated With Reduced Infection Severity and Lower Cost Compared With Standard Urine Culture in Patients With Complicated or Persistently Recurrent Urinary Tract Infections: Err 真实世界的证据表明,在并发或持续复发性尿路感染患者中,与标准尿培养相比,将分子检测与集合抗生素敏感性检测相结合的新型诊断方法可降低感染严重程度和成本:错误
Pub Date : 2024-05-01 DOI: 10.1097/ju9.0000000000000148
{"title":"Real-World Evidence That a Novel Diagnostic Combining Molecular Testing With Pooled Antibiotic Susceptibility Testing is Associated With Reduced Infection Severity and Lower Cost Compared With Standard Urine Culture in Patients With Complicated or Persistently Recurrent Urinary Tract Infections: Err","authors":"","doi":"10.1097/ju9.0000000000000148","DOIUrl":"https://doi.org/10.1097/ju9.0000000000000148","url":null,"abstract":"","PeriodicalId":508272,"journal":{"name":"JU Open Plus","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141030871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and Validation of Prognostic Nomogram to Predict Overall Survival for Older Patients Who Age 75 Years or Older With Urothelial Carcinoma of Bladder 开发并验证预测 75 岁或以上膀胱尿路上皮癌老年患者总生存期的预后提名图
Pub Date : 2024-05-01 DOI: 10.1097/ju9.0000000000000132
Junwei Li, Yanfang Ye, Xiaojing Li, Xinxin Xie, Tao Qin
Age is an important factor for prognostic factor in bladder cancer. However, most clinical studies targeting bladder cancer have limited the upper age limit to 75 years. With the higher age of diagnosis of older patients with bladder cancer, there is a lack of prognostic data for bladder cancer at advanced ages. In this study, we analyzed the prognostic factors of older patients with bladder cancer 75 years or older using Surveillance, Epidemiology, and End Results (SEER) data. Clinical parameters that constitute potential risk factors were analyzed by downloading a total of 13,505 patients with bladder cancer from the SEER database using univariate and multifactorial Cox proportional risk regression. Nomogram was constructed based on parameters significantly associated with overall survival (OS). The consistency index (c-index) and area under the curve were used to evaluate the predictive performance of the model. From the SEER database, we analyzed 13,505 cases and found that the median survival time for the whole cohort was 52 months. However, the median survival was 11 months, 8 months, and 6 months in 75 to 79 years subgroup, 80 to 84 years subgroup, and older than 85 years subgroup, when patients were diagnosed with stage IV. OS was poorer in the high histological grade patients. Furthermore, it was found that patients with lymph node metastasis had a significantly unfavorable prognosis than those with negative lymph nodes. The more advanced stage and distant metastases of patients had the shorter survival. Patients who underwent surgery had better overall survival than nonsurgical patients, and chemotherapy had prolonged survival. Conversely, survival was documented to be shorter with radiotherapy than those without radiotherapy. The overall prognosis of older patients with bladder cancer was poor, especially in patients with lymph node metastasis, high histological grade, and advanced stage, while a combination of surgery and chemotherapy could prolong survival.
年龄是影响膀胱癌预后的一个重要因素。然而,大多数针对膀胱癌的临床研究都将年龄上限限制在 75 岁。由于老年膀胱癌患者的确诊年龄较高,因此缺乏高龄膀胱癌的预后数据。在这项研究中,我们利用监测、流行病学和最终结果(SEER)数据分析了 75 岁或以上老年膀胱癌患者的预后因素。 我们从 SEER 数据库中下载了 13,505 名膀胱癌患者,采用单变量和多因素 Cox 比例风险回归分析了构成潜在风险因素的临床参数。根据与总生存期(OS)显著相关的参数构建了提名图。一致性指数(c-index)和曲线下面积用于评估模型的预测性能。 我们从 SEER 数据库中分析了 13,505 个病例,发现整个队列的中位生存时间为 52 个月。然而,在确诊为 IV 期的患者中,75 至 79 岁亚组、80 至 84 岁亚组和 85 岁以上亚组的中位生存期分别为 11 个月、8 个月和 6 个月。组织学分级高的患者的 OS 较差。此外,研究还发现,淋巴结转移患者的预后明显差于淋巴结阴性患者。越是晚期和远处转移的患者生存期越短。接受手术治疗的患者总生存期优于未接受手术治疗的患者,而化疗可延长患者的生存期。相反,接受放疗的患者的生存期要短于未接受放疗的患者。 老年膀胱癌患者的总体预后较差,尤其是淋巴结转移、组织学分级高和晚期的患者,而手术和化疗相结合可延长患者的生存期。
{"title":"Development and Validation of Prognostic Nomogram to Predict Overall Survival for Older Patients Who Age 75 Years or Older With Urothelial Carcinoma of Bladder","authors":"Junwei Li, Yanfang Ye, Xiaojing Li, Xinxin Xie, Tao Qin","doi":"10.1097/ju9.0000000000000132","DOIUrl":"https://doi.org/10.1097/ju9.0000000000000132","url":null,"abstract":"\u0000 \u0000 Age is an important factor for prognostic factor in bladder cancer. However, most clinical studies targeting bladder cancer have limited the upper age limit to 75 years. With the higher age of diagnosis of older patients with bladder cancer, there is a lack of prognostic data for bladder cancer at advanced ages. In this study, we analyzed the prognostic factors of older patients with bladder cancer 75 years or older using Surveillance, Epidemiology, and End Results (SEER) data.\u0000 \u0000 \u0000 \u0000 Clinical parameters that constitute potential risk factors were analyzed by downloading a total of 13,505 patients with bladder cancer from the SEER database using univariate and multifactorial Cox proportional risk regression. Nomogram was constructed based on parameters significantly associated with overall survival (OS). The consistency index (c-index) and area under the curve were used to evaluate the predictive performance of the model.\u0000 \u0000 \u0000 \u0000 From the SEER database, we analyzed 13,505 cases and found that the median survival time for the whole cohort was 52 months. However, the median survival was 11 months, 8 months, and 6 months in 75 to 79 years subgroup, 80 to 84 years subgroup, and older than 85 years subgroup, when patients were diagnosed with stage IV. OS was poorer in the high histological grade patients. Furthermore, it was found that patients with lymph node metastasis had a significantly unfavorable prognosis than those with negative lymph nodes. The more advanced stage and distant metastases of patients had the shorter survival. Patients who underwent surgery had better overall survival than nonsurgical patients, and chemotherapy had prolonged survival. Conversely, survival was documented to be shorter with radiotherapy than those without radiotherapy.\u0000 \u0000 \u0000 \u0000 The overall prognosis of older patients with bladder cancer was poor, especially in patients with lymph node metastasis, high histological grade, and advanced stage, while a combination of surgery and chemotherapy could prolong survival.\u0000","PeriodicalId":508272,"journal":{"name":"JU Open Plus","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141034191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How Effective Is Ureteroscopic Irrigation at Evacuating Stone Dust? 输尿管镜灌洗排出结石粉尘的效果如何?
Pub Date : 2024-05-01 DOI: 10.1097/ju9.0000000000000150
Bingyuan Yang, Aditi Ray, James Zhang, Ben Turney
Ureteroscopic laser lithotripsy results in the formation of small and numerous stone fragments. These have the potential to act as a nidus for stone recurrence, and the effectiveness of irrigation via the ureteroscope at clearing them is not well understood. Using an in vitro quartz-based model, fragments of known sizes from <63 µm to 2mm are irrigated at rates of 15 mL/min, 30 mL/min and 120 mL/min. Clinically achievable rates of 15-30 mL/min are unable to wash out larger particles >500 µm, and even 120 mL/min irrigation was able to wash out less than half of these larger particles. Complete stone clearance is unlikely to be achievable by intraoperative irrigation alone and requires additional technologies such as suction.
输尿管镜激光碎石术会形成小而多的结石碎片。这些碎片有可能成为结石复发的巢穴,而通过输尿管镜灌洗清除这些碎片的效果尚不十分清楚。使用基于石英的体外模型,已知大小为 500 微米的碎石,即使是 120 毫升/分钟的冲洗,也只能冲洗出不到一半的较大颗粒。仅靠术中冲洗不太可能完全清除结石,还需要额外的技术,如抽吸。
{"title":"How Effective Is Ureteroscopic Irrigation at Evacuating Stone Dust?","authors":"Bingyuan Yang, Aditi Ray, James Zhang, Ben Turney","doi":"10.1097/ju9.0000000000000150","DOIUrl":"https://doi.org/10.1097/ju9.0000000000000150","url":null,"abstract":"Ureteroscopic laser lithotripsy results in the formation of small and numerous stone fragments. These have the potential to act as a nidus for stone recurrence, and the effectiveness of irrigation via the ureteroscope at clearing them is not well understood. Using an in vitro quartz-based model, fragments of known sizes from <63 µm to 2mm are irrigated at rates of 15 mL/min, 30 mL/min and 120 mL/min. Clinically achievable rates of 15-30 mL/min are unable to wash out larger particles >500 µm, and even 120 mL/min irrigation was able to wash out less than half of these larger particles. Complete stone clearance is unlikely to be achievable by intraoperative irrigation alone and requires additional technologies such as suction.","PeriodicalId":508272,"journal":{"name":"JU Open Plus","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141042668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complex Buccal Graft Urethroplasty Combined With HoLEP in the Setting of Concomitant Urethral Stricture Disease and Severe Benign Prostatic Hyperplasia: A Case Report 尿道狭窄症和严重良性前列腺增生症并存时的复合颊部移植尿道成形术与 HoLEP 联合应用:病例报告
Pub Date : 2024-05-01 DOI: 10.1097/ju9.0000000000000139
L. R. Garabed, Stephanie Wang, Malek Meskawi, N. Bhojani, Daniel Liberman
Urethral strictures and benign prostatic hyperplasia (BPH) are 2 common causes of urinary obstruction and urinary emptying symptoms. While urethroplasty and endoscopic management of BPH have been extensively discussed in the literature when performed on their own, a case of simultaneous urethroplasty and endoscopic management of BPH has not been previously described in the literature. We present the case of a 75-year-old man with significant BPH and concomitant bulbar obliterative urethral stricture. After discussion of treatment options with the patient, we elected to perform both holmium LASER enucleation of the prostate (HoLEP) of a 200cc prostate and buccal graft urethroplasty during the same surgery. The HoLEP was performed through a dorsal urethrotomy in anticipation of urethroplasty. Nontransecting anastomotic repair was then combined with the buccal graft urethroplasty. The patient did not have any acute postoperative complications and had no recurrence. He reported improvements in outcome questionnaire scores and uroflow parameters at the 12-month follow-up. This case presentation is the first to report on simultaneous complex urethroplasty and endoscopic management of BPH, specifically HoLEP. It shows that this approach can lead to positive urinary outcomes without added complications and with lasting outcomes, thereby allowing the use of a combined surgical approach.
尿道狭窄和良性前列腺增生症(BPH)是导致排尿障碍和排空症状的两个常见原因。虽然尿道成形术和内窥镜治疗良性前列腺增生症单独进行时已在文献中进行了广泛讨论,但同时进行尿道成形术和内窥镜治疗良性前列腺增生症的病例在以前的文献中还没有描述过。 我们介绍的病例是一名 75 岁的男性,患有严重的良性前列腺增生症,同时伴有球部闭塞性尿道狭窄。在与患者讨论了治疗方案后,我们选择在同一手术中同时进行 200cc 前列腺的钬激光前列腺去核术(HoLEP)和口腔移植尿道成形术。前列腺钬激光剜除术通过背侧尿道切开术进行,以备尿道成形术。然后将非交叉吻合器修复与颊侧移植尿道成形术结合起来。患者术后没有出现任何急性并发症,也没有复发。在 12 个月的随访中,他的结果问卷评分和尿流参数都有所改善。 该病例首次报告了同时进行复杂尿道成形术和内窥镜治疗良性前列腺增生症的情况,特别是HoLEP。它表明,这种方法可以在不增加并发症的情况下获得积极的排尿效果,而且效果持久,因此可以使用联合手术方法。
{"title":"Complex Buccal Graft Urethroplasty Combined With HoLEP in the Setting of Concomitant Urethral Stricture Disease and Severe Benign Prostatic Hyperplasia: A Case Report","authors":"L. R. Garabed, Stephanie Wang, Malek Meskawi, N. Bhojani, Daniel Liberman","doi":"10.1097/ju9.0000000000000139","DOIUrl":"https://doi.org/10.1097/ju9.0000000000000139","url":null,"abstract":"\u0000 \u0000 Urethral strictures and benign prostatic hyperplasia (BPH) are 2 common causes of urinary obstruction and urinary emptying symptoms. While urethroplasty and endoscopic management of BPH have been extensively discussed in the literature when performed on their own, a case of simultaneous urethroplasty and endoscopic management of BPH has not been previously described in the literature.\u0000 \u0000 \u0000 \u0000 We present the case of a 75-year-old man with significant BPH and concomitant bulbar obliterative urethral stricture. After discussion of treatment options with the patient, we elected to perform both holmium LASER enucleation of the prostate (HoLEP) of a 200cc prostate and buccal graft urethroplasty during the same surgery. The HoLEP was performed through a dorsal urethrotomy in anticipation of urethroplasty. Nontransecting anastomotic repair was then combined with the buccal graft urethroplasty. The patient did not have any acute postoperative complications and had no recurrence. He reported improvements in outcome questionnaire scores and uroflow parameters at the 12-month follow-up.\u0000 \u0000 \u0000 \u0000 This case presentation is the first to report on simultaneous complex urethroplasty and endoscopic management of BPH, specifically HoLEP. It shows that this approach can lead to positive urinary outcomes without added complications and with lasting outcomes, thereby allowing the use of a combined surgical approach.\u0000","PeriodicalId":508272,"journal":{"name":"JU Open Plus","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141053294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Robotic Ureterolithotomy for Retained Stent With Massive Encrustation: Case Report and Review of the Literature 机器人输尿管结石切除术治疗大面积结石的支架残留:病例报告与文献综述
Pub Date : 2024-05-01 DOI: 10.1097/ju9.0000000000000146
Lily Kong, N. Coddington, Gary Shahinyan, Janet B. Kukreja, Brian J. Flynn
Massive encrustation is a rare complication of retained foreign bodies in the urinary tract. Large stone size and coexisting artificial material can limit endoscopic options, necessitating surgical removal. We present a case of massive encrustation of a retained ureteral stent treated with robotic-assisted laparoscopic ureterolithotomy.
大块结石是尿路异物滞留的一种罕见并发症。结石体积大、同时存在人工材料会限制内镜手术的选择,因此必须进行手术切除。我们介绍了一例采用机器人辅助腹腔镜输尿管碎石术治疗留置输尿管支架大量结石的病例。
{"title":"Robotic Ureterolithotomy for Retained Stent With Massive Encrustation: Case Report and Review of the Literature","authors":"Lily Kong, N. Coddington, Gary Shahinyan, Janet B. Kukreja, Brian J. Flynn","doi":"10.1097/ju9.0000000000000146","DOIUrl":"https://doi.org/10.1097/ju9.0000000000000146","url":null,"abstract":"Massive encrustation is a rare complication of retained foreign bodies in the urinary tract. Large stone size and coexisting artificial material can limit endoscopic options, necessitating surgical removal. We present a case of massive encrustation of a retained ureteral stent treated with robotic-assisted laparoscopic ureterolithotomy.","PeriodicalId":508272,"journal":{"name":"JU Open Plus","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141054647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
JUOP Top Reviewers 2023 2023 年 JUOP 热门评论
Pub Date : 2024-05-01 DOI: 10.1097/ju9.0000000000000142
{"title":"JUOP Top Reviewers 2023","authors":"","doi":"10.1097/ju9.0000000000000142","DOIUrl":"https://doi.org/10.1097/ju9.0000000000000142","url":null,"abstract":"","PeriodicalId":508272,"journal":{"name":"JU Open Plus","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141055953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Partial Versus Radical Nephrectomy: Comparison of Postoperative Complications and Contribution to Mortality 肾部分切除术与肾根治术:术后并发症及其对死亡率影响的比较
Pub Date : 2024-05-01 DOI: 10.1097/ju9.0000000000000147
A. Houjaij, O. Darwish, Jacob Rubin, Raymond Pominville, Pradeep Arora, Mohsin Shiekh, Csaba Gajdos, Nader D. Nader
Partial nephrectomy is the preferred treatment method for certain kidney tumors owing to its nephron-preserving benefit. We aimed to compare the occurrence and importance of complications after radical (RN) or partial (PN) nephrectomy for localized renal cell carcinoma (RCC) and contribution to patient mortality. All RCC cases were extracted from the National Surgical Quality Improvement Program between 2005 and 2017. All-cause mortality was the primary endpoint that defined a failure to rescue (FTR) after the occurrences of complications. Propensity score matching (PSM) was performed to adjust for confounding variables between the 2 groups. The exclusion criteria included patients on dialysis, those with distant metastases, and those with concurrent procedures. Null hypotheses were rejected when P-values were < .05. The database included 24,830 patients, with 22,015 in the RN group and 2815 in the PN. After PSM, 2226 patients after PN were matched 1:1 to an equal number of patients who underwent RN. Overall, postoperative complications occurred in 20.5% after RN, more frequent than 15.9% after PN (P < .001). While the mortality rates were similar, patients were more likely to experience blood transfusion and reintubation, as well as longer hospital stay after RN, while they were likely to have more infectious complications, including abdominal abscess, and more likely to return to the operating room after PN. In both groups, cardiac and respiratory complications were associated with FTR, leading to mortality. Excessive bleeding (requiring transfusion) was also a significant cause of death after RN but not after PN. When planning PN or RN, patients should be counseled on the risks of their selective procedure and the potential increased mortality risk with certain complications. These risks should be weighed against the benefit of those cancer surgeries.
肾部分切除术因其保留肾小球的优点而成为某些肾肿瘤的首选治疗方法。我们旨在比较局部肾细胞癌(RCC)根治性(RN)或肾部分切除术后并发症的发生率和重要性,以及对患者死亡率的影响。 2005年至2017年期间的所有RCC病例均来自国家外科质量改进计划。全因死亡率是定义并发症发生后抢救失败(FTR)的主要终点。进行倾向评分匹配(PSM)以调整两组之间的混杂变量。排除标准包括透析患者、远处转移患者和同时进行手术的患者。当P值小于0.05时,拒绝零假设。 数据库中包括 24830 名患者,其中 RN 组 22015 人,PN 组 2815 人。在 PSM 之后,2226 名接受过 PN 的患者与同等数量的接受过 RN 的患者进行了 1:1 匹配。总体而言,RN 术后并发症发生率为 20.5%,高于 PN 术后的 15.9%(P < .001)。虽然死亡率相似,但 RN 术后患者更有可能输血和再次插管,住院时间也更长,而 PN 术后患者可能出现更多感染性并发症,包括腹腔脓肿,也更有可能返回手术室。在两组患者中,心脏和呼吸系统并发症都与 FTR 相关,并导致死亡。大出血(需要输血)也是 RN 后死亡的一个重要原因,但不是 PN 后死亡的一个重要原因。 在计划进行 PN 或 RN 时,应就选择性手术的风险以及某些并发症可能增加的死亡率风险向患者提供咨询。应将这些风险与癌症手术的益处进行权衡。
{"title":"Partial Versus Radical Nephrectomy: Comparison of Postoperative Complications and Contribution to Mortality","authors":"A. Houjaij, O. Darwish, Jacob Rubin, Raymond Pominville, Pradeep Arora, Mohsin Shiekh, Csaba Gajdos, Nader D. Nader","doi":"10.1097/ju9.0000000000000147","DOIUrl":"https://doi.org/10.1097/ju9.0000000000000147","url":null,"abstract":"\u0000 \u0000 Partial nephrectomy is the preferred treatment method for certain kidney tumors owing to its nephron-preserving benefit. We aimed to compare the occurrence and importance of complications after radical (RN) or partial (PN) nephrectomy for localized renal cell carcinoma (RCC) and contribution to patient mortality.\u0000 \u0000 \u0000 \u0000 All RCC cases were extracted from the National Surgical Quality Improvement Program between 2005 and 2017. All-cause mortality was the primary endpoint that defined a failure to rescue (FTR) after the occurrences of complications. Propensity score matching (PSM) was performed to adjust for confounding variables between the 2 groups. The exclusion criteria included patients on dialysis, those with distant metastases, and those with concurrent procedures. Null hypotheses were rejected when P-values were < .05.\u0000 \u0000 \u0000 \u0000 The database included 24,830 patients, with 22,015 in the RN group and 2815 in the PN. After PSM, 2226 patients after PN were matched 1:1 to an equal number of patients who underwent RN. Overall, postoperative complications occurred in 20.5% after RN, more frequent than 15.9% after PN (P < .001). While the mortality rates were similar, patients were more likely to experience blood transfusion and reintubation, as well as longer hospital stay after RN, while they were likely to have more infectious complications, including abdominal abscess, and more likely to return to the operating room after PN. In both groups, cardiac and respiratory complications were associated with FTR, leading to mortality. Excessive bleeding (requiring transfusion) was also a significant cause of death after RN but not after PN.\u0000 \u0000 \u0000 \u0000 When planning PN or RN, patients should be counseled on the risks of their selective procedure and the potential increased mortality risk with certain complications. These risks should be weighed against the benefit of those cancer surgeries.\u0000","PeriodicalId":508272,"journal":{"name":"JU Open Plus","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141058274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing Urology Resident Training in Vasectomies Through a 3D Printed Simulation 通过 3D 打印模拟加强泌尿外科住院医师输精管结扎术培训
Pub Date : 2024-05-01 DOI: 10.1097/ju9.0000000000000135
Julio A. Yanes, David A. Velasquez, Mary Rostom, Francis Petrella, P. Saba, Lauren Shepard, A. Ghazi, Ranjith Ramasamy
{"title":"Enhancing Urology Resident Training in Vasectomies Through a 3D Printed Simulation","authors":"Julio A. Yanes, David A. Velasquez, Mary Rostom, Francis Petrella, P. Saba, Lauren Shepard, A. Ghazi, Ranjith Ramasamy","doi":"10.1097/ju9.0000000000000135","DOIUrl":"https://doi.org/10.1097/ju9.0000000000000135","url":null,"abstract":"","PeriodicalId":508272,"journal":{"name":"JU Open Plus","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141035554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Moving the Needle: Integrating Available Risk Stratification Tools for Optimizing Diagnosis of Prostate Cancer 移动针头:整合现有风险分层工具,优化前列腺癌诊断
Pub Date : 2024-05-01 DOI: 10.1097/ju9.0000000000000154
Akshay Sood
{"title":"Moving the Needle: Integrating Available Risk Stratification Tools for Optimizing Diagnosis of Prostate Cancer","authors":"Akshay Sood","doi":"10.1097/ju9.0000000000000154","DOIUrl":"https://doi.org/10.1097/ju9.0000000000000154","url":null,"abstract":"","PeriodicalId":508272,"journal":{"name":"JU Open Plus","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141030639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JU Open Plus
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1